City of Blue Mound Defective Breast Mesh & Implant Attorneys — Attorney911 Brings Ralph Manginello’s 27+ Years of Trial Experience and Federal Court Admission to the Northern District of Texas: We Litigate Allergan BIOCELL Textured Implants (Recalled July 2019, MDL 2921 Before Judge Martinotti, Bellwether October 19, 2026), AlloDerm ADM, and GalaFLEX P4HB Scaffolds Under 21 CFR Parts 803, 807, and 814 — Lupe Peña Former Insurance Defense Attorney Conducts Full Consultations in Fluent Spanish — CD30+/ALK- BIA-ALCL Pathology, BIA-SCC & Capsular Contracture Claims Filed Under Texas CPRC § 16.003 Two-Year Statute of Limitations — Riegel Parallel-Claim Survivability and Lohr Non-Preemption Authority Applied to $50M+ Firm Recovery Record & Active $10M Bermudez v. Pi Kappa Phi Litigation — Free Consultation, No Fee Unless We Recover Compensation for You, 1-888-ATTY-911, Hablamos Español
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Blue Mound: The Complete Guide for Women, Families, and Survivors If you are a woman in Blue Mound who underwent breast reconstruction, augmentation, or a mastopexy "internal bra" procedure, you likely made that decision with a focus on healing, restoration, or confidence. For many members of our Blue Mound community, these surgeries follow a courageous battle with breast cancer or a proactive choice to manage hereditary risks like the BRCA1 or BRCA2 mutations. You trusted that the medical devices placed in your body—the surgical meshes, acellular dermal matrices (ADM), and bioabsorbable scaffolds—were thoroughly vetted for safety and effectiveness. However, a growing body of evidence, whistleblower testimony, and FDA communications have revealed a troubling reality for patients in Blue Mound and throughout Tarrant County. Many of these products, including brands like GalaFLEX, Phasix, and various acellular dermal matrices like FlexHD and AlloMax, were never formally approved by the FDA for use in breast tissue. Instead, they reached Blue Mound operating rooms through a regulatory loophole known as the 510(k) clearance pathway, based on "substantial equivalence" to products used in entirely different parts of the body, such as hernia repairs…
